We have developed a robust automated procedure for the simultaneous visualization of HER2 protein, the HER2 gene, and CEN17 in FFPE xenograft tumor tissue sections and have demonstrated its accuracy in the analysis of FFPE breast cancer TMA slides. This evidence concerns the gene ERBB2 and breast cancer.